cystic fibrosis. Cystic fibrosis with pulmonary manifestations
Conditions
Interventions
Intervention 1: Intervention group: In addition to antibiotic therapy and conventional chest physiotherapy, patients underwent NIV with BIPAP (NIV on days 2, 4 and 6 admitted for 2 hours) and PEP (on
Sponsors
Reasearch Deputy, Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
5 Years to 14 Years
Inclusion criteria
Inclusion criteria: • Patients with CF diagnosis• Patients aged 5 to 14 years• Patients with exacerbation of lung disease with FEV1 = 20-70% in initial spirometry when admitted
Exclusion criteria
Exclusion criteria: • Patients with reluctance to continue participating in the study• Patients who can not be traced to a cause such as death, transference to another city, etc. during the study period.• Patients who do not have adequate compilation to continue treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Forced expiratory volume in the first second. Timepoint: In the second and last day of the admission. Method of measurement: By using spirometry device.;FEV1/FVC. Timepoint: In the second and last day of the admission. Method of measurement: By using spirometry device.;Peak expiratory flow. Timepoint: In the second and last day of the admission. Method of measurement: By using peak flow-meter device. | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of Exacerebration within six months. Timepoint: within six months. Method of measurement: Cheklist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNemat Bilan
Pediatric Health Research Center, Tabriz University of Medical Sciences
Outcome results
None listed